“The 2023 shared clinical decision-making RSV vaccination recommendation was made in the setting of uncertainty in some portions of the evidence profile.” However, more evidence has informed the updated guidelines.
(RSV) vaccines from GSK and Pfizer for people aged 60 years and older, according to a recent CDC statement. The vaccines should be administered using shared clinical decision-making, meaning individuals can receive a single dose of the vaccine based on conversations with their health care ...
“There was very strong desire to move away from shared clinical decision-making after hearing a lot of comments that it made it difficult for physicians and pharmacists to implement RSV vaccines,” Healio |Infectious Disease NewsEditorial Board MemberWilliam Schaffner, MD,a professor of ...
The new guidance stops short of a full-throated recommendation for all eligible older adults to get the shots. Instead, the panel called for"shared clinical decision-making"between doctors and patients to decide whether the individual benefits outweigh the risks. "This means these individuals may ...
To prevent RSV infection, the CDC recommends that adults 60 years or older should receive a single dose of an RSV vaccine through shared clinical decision-making, which entails discussions between health care providers and patients to determine the vaccine’s benefits. Adults who are at highe...
syncytial virus (RSV) vaccines were approved by the United States (US) Food and Drug Administration (FDA) for adults aged 鈮 60 years and recommended by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) using shared clinical decision-making (SCDM...
approved last fall, recommends the vaccine for people 60 and older if a health care provider believes vaccination would be beneficial. That recommendation — called shared decision-making — has confused physicians and some would-be recipients, and has probably depressed uptake of the ...
In the end, the committee voted 9 – 5 to recommend that people 65 and older “may” get an RSV vaccine, based on shared decision-making, a term that typically means a discussion between patients and their doctors. With these vaccines, it could also mean a discussion between patients and...
来源:Vaccine前研 ✎我国科学家发现新冠病毒新血清型,为研发广谱新冠疫苗提供依据 中国科学院微生物研究所的团队发现新冠病毒变异株BA.2.86已演化成新血清型,这一发现对未来的疫苗和抗体研发具有重要意义。研究通过小鼠血清交叉中和分析,确定BA.2.86与现有XBB变异株的抗原性有明显区别,暗示基于XBB的疫苗可能无法充分抵...
"Unlike a universal recommendation where there's a clear call to vaccinate, with shared clinical decision-making the call to action is to discuss with a healthcare provider -- a less clear message." The recommendation also clarified that although the vaccine is universally recommended for those ...